CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

OSL:CONTX • SE0014731154

3.21 NOK
+0.02 (+0.63%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CONTX. CONTX was compared to 10 industry peers in the Health Care Technology industry. CONTX has only an average score on both its financial health and profitability. CONTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • In the past year CONTX had a positive cash flow from operations.
  • Of the past 5 years CONTX 4 years were profitable.
  • CONTX had a positive operating cash flow in each of the past 5 years.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • The Return On Assets of CONTX (3.07%) is comparable to the rest of the industry.
  • The Return On Equity of CONTX (3.95%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 2.67%, CONTX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 8.41%.
  • The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(2.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROIC 2.67%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.17%, CONTX is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • CONTX's Profit Margin has improved in the last couple of years.
  • CONTX has a worse Operating Margin (2.90%) than 60.00% of its industry peers.
  • CONTX's Operating Margin has improved in the last couple of years.
  • CONTX has a better Gross Margin (97.62%) than 90.00% of its industry peers.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
  • CONTX has about the same amout of shares outstanding than it did 1 year ago.
  • CONTX has about the same amout of shares outstanding than it did 5 years ago.
  • CONTX has a worse debt/assets ratio than last year.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
  • CONTX has a Debt to FCF ratio (5.01) which is comparable to the rest of the industry.
  • CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • CONTX has a Debt to Equity ratio of 0.07. This is in the better half of the industry: CONTX outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACC0.3
WACC8.97%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.79. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX's Current ratio of 4.79 is amongst the best of the industry. CONTX outperforms 90.00% of its industry peers.
  • A Quick Ratio of 4.70 indicates that CONTX has no problem at all paying its short term obligations.
  • CONTX has a Quick ratio of 4.70. This is amongst the best in the industry. CONTX outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.7
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.70%.
  • The Earnings Per Share has been growing by 27.26% on average over the past years. This is a very strong growth
  • CONTX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.08%.
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%

3.2 Future

  • CONTX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.44% yearly.
  • The Revenue is expected to decrease by -1.43% on average over the next years.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 64.20 indicates a quite expensive valuation of CONTX.
  • CONTX's Price/Earnings ratio is in line with the industry average.
  • CONTX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.16.
  • CONTX is valuated quite expensively with a Price/Forward Earnings ratio of 26.71.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX is on the same level as its industry peers.
  • CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 64.2
Fwd PE 26.71
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, CONTX is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 139.94
EV/EBITDA 15.62
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CONTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CONTX's earnings are expected to decrease with -7.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.36
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.02, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.00% of the companies listed in the same industry.
  • CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/17/2026, 7:00:00 PM)

3.21

+0.02 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap248.36M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (27.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
Industry RankSector Rank
PE 64.2
Fwd PE 26.71
P/S 2.08
P/FCF 139.94
P/OCF 26.36
P/B 2.59
P/tB 2.66
EV/EBITDA 15.62
EPS(TTM)0.05
EY1.56%
EPS(NY)0.12
Fwd EY3.74%
FCF(TTM)0.02
FCFY0.71%
OCF(TTM)0.12
OCFY3.79%
SpS1.55
BVpS1.24
TBVpS1.21
PEG (NY)N/A
PEG (5Y)2.36
Graham Number1.18
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROCE 3.38%
ROIC 2.67%
ROICexc 8.83%
ROICexgc 9.67%
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
FCFM 1.48%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Debt/EBITDA 0.55
Cap/Depr 92.01%
Cap/Sales 6.39%
Interest Coverage 250
Cash Conversion 79.95%
Profit Quality 46.76%
Current Ratio 4.79
Quick Ratio 4.7
Altman-Z N/A
F-Score5
WACC8.97%
ROIC/WACC0.3
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.